CADL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Candel Therapeutics Inc (CADL).


$281.89M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

CADL Market Cap. (MRY)


CADL Shares Outstanding (MRY)


CADL Assets (MRY)


Total Assets

$106.87M

Total Liabilities

$40.54M

Total Investments

$0

CADL Income (MRY)


Revenue

$0

Net Income

-$55.18M

Operating Expense

$33.37M

CADL Cash Flow (MRY)


CF Operations

-$27.02M

CF Investing

-$16.00K

CF Financing

$94.28M

CADL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

CADL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$106,866,000 (159.38%)

$41,201,000 (-46.97%)

$77,691,000 (-12.91%)

$89,205,000 (133.02%)

Assets Current

$103,804,000 (182.10%)

$36,797,000 (-48.85%)

$71,945,000 (-15.30%)

$84,945,000 (141.69%)

Assets Non-Current

$3,062,000 (-30.47%)

$4,404,000 (-23.36%)

$5,746,000 (34.88%)

$4,260,000 (35.84%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$66,327,000 (420.42%)

$12,745,000 (-73.29%)

$47,714,000 (-25.61%)

$64,137,000 (372.21%)

Property Plant & Equipment Net

$2,733,000 (-32.05%)

$4,022,000 (-26.61%)

$5,480,000 (42.86%)

$3,836,000 (37.64%)

Cash & Equivalents

$102,920,000 (188.46%)

$35,679,000 (-49.26%)

$70,324,000 (-15.34%)

$83,066,000 (136.97%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$144,000 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$237,000 (-43.84%)

$422,000 (11.05%)

$380,000 (-76.10%)

$1,590,000 (72.64%)

Accumulated Retained Earnings (Deficit)

-$192,205,000 (-40.27%)

-$137,028,000 (-38.29%)

-$99,089,000 (-23.41%)

-$80,295,000 (-81.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$13,471,000 (-40.82%)

$22,762,000 (-0.17%)

$22,800,000 (3971.43%)

$560,000 (-40.80%)

Debt Current

$10,461,000 (11.22%)

$9,406,000 (1927.16%)

$464,000 (0%)

$0 (0%)

Debt Non-Current

$3,010,000 (-77.46%)

$13,356,000 (-40.20%)

$22,336,000 (3888.57%)

$560,000 (15.94%)

Total Liabilities

$40,539,000 (42.46%)

$28,456,000 (-5.07%)

$29,977,000 (19.58%)

$25,068,000 (96.09%)

Liabilities Current

$37,529,000 (164.59%)

$14,184,000 (152.61%)

$5,615,000 (4.72%)

$5,362,000 (13.77%)

Liabilities Non-Current

$3,010,000 (-78.91%)

$14,272,000 (-41.42%)

$24,362,000 (23.63%)

$19,706,000 (144.16%)

CADL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,057,000 (1.24%)

$13,885,000 (-1.24%)

$14,060,000 (31.73%)

$10,673,000 (106.00%)

Research & Development Expense

$19,314,000 (-21.19%)

$24,506,000 (17.89%)

$20,787,000 (36.95%)

$15,178,000 (73.38%)

Operating Expenses

$33,371,000 (-13.08%)

$38,391,000 (10.17%)

$34,847,000 (34.80%)

$25,851,000 (85.51%)

Interest Expense

$2,090,000 (-19.46%)

$2,595,000 (429.59%)

$490,000 (824.53%)

$53,000 (147.75%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$55,177,000 (-45.44%)

-$37,939,000 (-101.87%)

-$18,794,000 (47.97%)

-$36,124,000 (-104.32%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$55,177,000 (-45.44%)

-$37,939,000 (-101.87%)

-$18,794,000 (47.97%)

-$36,124,000 (-104.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$55,177,000 (-45.44%)

-$37,939,000 (-101.87%)

-$18,794,000 (47.97%)

-$36,124,000 (-104.32%)

Weighted Average Shares

$31,675,076 (9.47%)

$28,935,289 (0.39%)

$28,823,480 (52.72%)

$18,873,048 (62.49%)

Weighted Average Shares Diluted

$31,675,076 (9.47%)

$28,935,289 (0.39%)

$28,823,480 (52.72%)

$18,873,048 (62.49%)

Earning Before Interest & Taxes (EBIT)

-$53,087,000 (-50.20%)

-$35,344,000 (-93.09%)

-$18,304,000 (49.26%)

-$36,071,000 (-102.75%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$33,371,000 (13.08%)

-$38,391,000 (-10.17%)

-$34,847,000 (-34.80%)

-$25,851,000 (-85.51%)

CADL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$16,000 (94.29%)

-$280,000 (78.41%)

-$1,297,000 (29.32%)

-$1,835,000 (-104.77%)

Net Cash Flow from Financing

$94,280,000 (78017.36%)

-$121,000 (-100.61%)

$19,974,000 (-72.18%)

$71,800,000 (14553.06%)

Net Cash Flow from Operations

-$27,023,000 (21.09%)

-$34,244,000 (-8.99%)

-$31,419,000 (-41.41%)

-$22,218,000 (-144.93%)

Net Cash Flow / Change in Cash & Cash Equivalents

$67,241,000 (294.09%)

-$34,645,000 (-171.90%)

-$12,742,000 (-126.69%)

$47,747,000 (59.83%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$16,000 (94.29%)

-$280,000 (78.41%)

-$1,297,000 (29.32%)

-$1,835,000 (-24.32%)

Issuance (Repayment) of Debt Securities

-$9,167,000 (0%)

$0 (0%)

$19,910,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$103,447,000 (0%)

$0 (0%)

$64,000 (-99.91%)

$71,800,000 (239233.33%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,312,000 (71.85%)

$3,091,000 (33.98%)

$2,307,000 (-22.14%)

$2,963,000 (40.63%)

Depreciation Amortization & Accretion

$1,264,000 (5.33%)

$1,200,000 (21.58%)

$987,000 (325.43%)

$232,000 (154.95%)

CADL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-468.80% (-228.06%)

-142.90% (-325.30%)

-33.60% (86.88%)

-256.00% (-328.78%)

Return on Average Assets (ROAA)

-118.60% (-69.67%)

-69.90% (-232.86%)

-21.00% (63.54%)

-57.60% (-37.14%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-2849.50% (-1508.07%)

-177.20% (-133.16%)

-76.00% (95.30%)

-1617.40% (-1681.28%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-4.99 (-344.65%)

-1.12 (59.26%)

-2.75 (32.73%)

-4.09

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

4.25 (27.40%)

3.34 (207.75%)

1.08 (-69.01%)

3.5

Debt to Equity Ratio (D/E)

0.61 (-72.64%)

2.23 (255.57%)

0.63 (60.61%)

0.39 (172.01%)

Earnings Per Share (EPS)

-1.74 (-32.82%)

-1.31 (-101.54%)

-0.65 (65.97%)

-1.91 (-25.66%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.85 (28.42%)

-1.19 (-5.11%)

-1.14 (10.91%)

-1.27 (-40.31%)

Book Value Per Share (BVPS)

2.09 (375.91%)

0.44 (-73.41%)

1.66 (-51.29%)

3.4 (267.47%)

Tangible Assets Book Value Per Share (TABVPS)

3.37 (136.94%)

1.42 (-47.16%)

2.69 (-42.99%)

4.73 (43.42%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-400.00%)

-1 (0%)

0 (0%)

-4

Enterprise Value Over EBITDA (EV/EBITDA)

-5.42 (-740.93%)

-0.65 (-481.66%)

0.17 (104.44%)

-3.81

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.77 (6.63%)

2.59 (-79.75%)

12.81 (-19.12%)

15.84 (112.44%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$27,039,000 (21.68%)

-$34,524,000 (-5.53%)

-$32,716,000 (-36.02%)

-$24,053,000 (-128.06%)

Enterprise Value (EV)

$281,086,661 (1175.69%)

$22,034,121 (854.42%)

-$2,920,661 (-102.14%)

$136,510,564

Earnings Before Tax (EBT)

-$55,177,000 (-45.44%)

-$37,939,000 (-101.87%)

-$18,794,000 (47.97%)

-$36,124,000 (-104.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$51,823,000 (-51.78%)

-$34,144,000 (-97.17%)

-$17,317,000 (51.68%)

-$35,839,000 (-102.48%)

Invested Capital

-$20,112,000 (-242.64%)

$14,100,000 (-42.57%)

$24,552,000 (1736.35%)

$1,337,000 (348.51%)

Working Capital

$66,275,000 (193.08%)

$22,613,000 (-65.91%)

$66,330,000 (-16.65%)

$79,583,000 (161.50%)

Tangible Asset Value

$106,866,000 (159.38%)

$41,201,000 (-46.97%)

$77,691,000 (-12.91%)

$89,205,000 (133.02%)

Market Capitalization

$281,887,661 (563.08%)

$42,512,121 (-17.80%)

$51,720,339 (-76.95%)

$224,354,564

Average Equity

$11,769,250 (-55.67%)

$26,547,500 (-52.52%)

$55,918,750 (296.22%)

$14,113,000 (189.32%)

Average Assets

$46,521,250 (-14.33%)

$54,302,000 (-39.25%)

$89,390,250 (42.45%)

$62,750,750 (49.08%)

Invested Capital Average

$1,863,000 (-90.66%)

$19,947,000 (-17.16%)

$24,078,500 (979.63%)

$2,230,250 (-88.62%)

Shares

32,475,537 (12.30%)

28,919,810 (0.09%)

28,894,044 (0.71%)

28,689,842 (15.70%)